Latest Videos

In this episode of Teach Me in 10, UNLV neuroscientist Dr. Rochelle Hines joins us to discuss the team’s latest findings, which show that mutations in ARHGEF9 — the gene that codes for collybistin — lead to ID through impaired α2 subunit function.

In this episode of Teach Me in 10, we speak with Helge Schnerr, global campaign manager at Sartorius, about the motivation behind this move, the game-changing features on the SF3 and how it all translates to empowering scientists.

Speaking at The Laboratory of the Future, April Quinn-Paquet, technical product manager at SCIEX presented her talk on data acquisition, processing and decision rules.

In this episode of Teach Me in 10, Lucy Lawrence is joined by Brian Godwin, director of reagent and assay development at Roche Sequencing to discuss primer extension target enrichment for NGS.

About six million Americans are currently living with Alzheimer’s disease and another six million are showing early signs of developing the disease. Researchers at UT Southwestern are working toward a solution that would prevent the disease from beginning.

Speaking at the 'Laboratory of The Future' online symposium, Jonas Anielski, PhD from Eppendorf, presented his talk on challenges to overcome and moving towards a digital experiment.

Speaking at The Laboratory of The Future, Adam Wheeler, from Thermo Fisher Scientific presented his talk on helping organizations realize the full potential of digital transformation to improve quality, efficiency and the user experience.

In this episode of Teach Me in 10 Lucy Lawrence and Hilary Sherman discuss some tips and tricks for harvesting adherent cells.

This video will cover the basics of antibodies, the reasons why you need flow cytometry–specific antibodies, and some basic best practices to achieve improved data and increase the likelihood of a successful outcome for flow cytometry experiments.

Drug transport can be thought of as the AD&E in ADME, as transporters are responsible for absorption, distribution, tissue-specific drug targeting, and elimination of drugs. Since they are involved in so much of the movement of a compound through the body, they can be involved in many drug‒drug interactions (DDI). The clearance of transporter substrates can be impacted by transporter inhibitors or inducers which can lead to toxicity or loss of efficacy.